Dr. Rande Harris Lazar, MD

Dr. Lazar practices at Otolaryngology Consultants Of Memphis in Memphis, Tennessee.

Dr. Lazar's NPI, 1841378403, was assigned on November 1, 2006. Dr. Lazar graduated from Universidad Autonoma de Guadalajara in 1978. Dr. Lazar holds Tennessee license 16275.

Dr. Lazar's primary practice is Otolaryngology Consultants of Memphis, at 791 Estate Place, Memphis, TN 38120. The practice phone is (901) 821-4300.

Dr. Lazar's primary practice is Otolaryngology Consultants Of Memphis in Memphis, Tennessee. Dr. Lazar is also affiliated with Methodist University Hospital. The medical group on file is Select Physical Therapy. Dmand AI also links Dr. Lazar to 2 more hospitals, 1 therapy and rehab clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lazar practices, 5 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Lazar's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dmand AI has Dr. Lazar's licenses on file in 3 states: Tennessee, New York and Ohio.

Dmand AI lists acute sinusitis, chronic nasal allergies, chronic sinusitis, ear eustachian tube disorders, ear infection, endoscopic sinus surgery, larynx and vocal cord disease and swimmer's ear among the conditions Dr. Lazar treats.

CMS data shows 3,479 Medicare services from Dr. Lazar across 16 procedure codes in 2024, for 764 Medicare patients. Medicare paid $184,829 for them.

CMS counts 764 Medicare patients who saw Dr. Lazar in 2024. The largest group is 65 to 74, with 332 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 21% are also on Medicaid. Their average risk score is 1.10, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Lazar's median patient age at 58, with 60% women.

In 2024, Dr. Lazar wrote 4,243 Medicare Part D claims for 1,172 patients. 95% of them were for generic drugs. CMS names the drug for 4,110 of them, across 34 drugs with 11 or more claims each, at $246,596 in total drug cost. In 2023, CMS named 3,961 claims across 36 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Lazar for performance year 2024, reported individually. Dr. Lazar accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 35 papers to Dr. Lazar. The most frequent topics are Sinusitis, Endoscopy and Tomography, X-Ray Computed. Dr. Lazar has published most often in Ear Nose Throat J. Dr. Lazar's most frequent co-authors are Ramzi T. Younis, MD, Ron Benson Mitchell, MD and Vinod Kumar Anand, MD.

CMS Open Payments shows 146 general payments to Dr. Lazar from 23 drug and device companies from 2016 to 2025. Grants make up the largest share, 38% of the total. KARL STORZ Endoscopy-America paid the most, $5,000.

Dmand AI lists 1 award for Dr. Lazar, most recently CMS Stage 1 2012 in 2012. Dr. Lazar serves on Cleveland Clinic Foundation Cleveland Ohio and Medical Executive Committee/ Chief of Staff at LeBonheur Children’s Medical Center-East Surgery Center Chairman of the Medical Executive Committee/ Chief of Staff at LeBonheur Children’s Medical Center-East Surgery Center for over 15 years.

Dr. Lazar graduated from Universidad Autonoma de Guadalajara in 1978.

Dr. Lazar is in network with 10 carriers, including Aetna, Cigna and United Healthcare. PPO plans come from the most carriers, 6. Check the plan with the practice before a visit.